BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Branquinho RT, de Mello CGC, Oliveira MT, Reis LES, Vieira PMA, Saúde-Guimarães DA, Mosqueira VCF, de Lana M. Lychnopholide in Poly(d,l-Lactide)-Block-Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases. Antimicrob Agents Chemother 2020;64:e01937-19. [PMID: 31988096 DOI: 10.1128/AAC.01937-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Karabasz A, Bzowska M, Szczepanowicz K. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature. Int J Nanomedicine 2020;15:8673-96. [PMID: 33192061 DOI: 10.2147/IJN.S231477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Mazzeti AL, Capelari-Oliveira P, Bahia MT, Mosqueira VCF. Review on Experimental Treatment Strategies Against Trypanosoma cruzi. J Exp Pharmacol 2021;13:409-32. [PMID: 33833592 DOI: 10.2147/JEP.S267378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sánchez Alberti A, Beer MF, Cerny N, Bivona AE, Fabian L, Morales C, Moglioni A, Malchiodi EL, Donadel OJ, Sülsen VP. In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection. ACS Omega 2022;7:968-78. [PMID: 35036760 DOI: 10.1021/acsomega.1c05560] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sülsen VP. Sesquiterpene Lactones and Diterpenes: Promising Therapeutic Candidates for Infectious Diseases, Neoplasms and Other Chronic Disorders. Molecules 2021;26:1251. [PMID: 33652593 DOI: 10.3390/molecules26051251] [Reference Citation Analysis]
5 Silva DF, Reis LES, Machado MGC, Dophine DD, de Andrade VR, de Lima WG, Andrade MS, Vilela JMC, Reis AB, Pound-Lana G, Rezende SA, Mosqueira VCF. Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics 2021;13:1061. [PMID: 34371752 DOI: 10.3390/pharmaceutics13071061] [Reference Citation Analysis]